WolverHeme Happy Hour
Podcast tekijän mukaan Bernard Marini, Anthony Perissinotti, et al.
35 Jaksot
-
Dex and the Cytokine City: Managing CRS with Bispecifics
Julkaistiin: 7.4.2025 -
LFGooo! The Rise, the Fall, and the Resurrection of Gemtuzumab in AML
Julkaistiin: 11.3.2025 -
Episode 32: Navigating a BlinatumoMAD World
Julkaistiin: 21.1.2025 -
The Aquila Study: Blowing Hot Air or a Soaring Success for Smoldering Multiple Myeloma
Julkaistiin: 15.1.2025 -
Pour Decisions, or ASH-olutely Fabulous? Reviewing 2024 ASH Lymphoma Updates
Julkaistiin: 24.12.2024 -
A Bunch of ASHholes Discuss Myeloma Abstracts
Julkaistiin: 16.11.2024 -
Cast your vote! Nivolumab vs. Brentuximab for Classical Hodgkin Lymphoma
Julkaistiin: 8.11.2024 -
Episode 27: Mantle Cell Masterclass with Tycel Phillips
Julkaistiin: 10.10.2024 -
Houston, we don't have a problem... with APOLLO
Julkaistiin: 28.8.2024 -
From Ancient Remedies to Modern Miracles: The Evolution of APL Treatment
Julkaistiin: 13.6.2024 -
Episode 24: Myeloma Madness with the Myeloma Man
Julkaistiin: 17.4.2024 -
Anthony and Bernie get rich on no-larabine! An ASH 2023 ALL discussion
Julkaistiin: 25.1.2024 -
LymphOMG: Pouring Over Lymphoma Abstracts from ASH
Julkaistiin: 29.12.2023 -
AMLchemy at ASH: Brewing Success with Menin Magic, MRD Mysteries, and Aza/Ven Alchemy
Julkaistiin: 19.12.2023 -
ASH Pregaming - Myeloma Madness with Manni and Papa Heme
Julkaistiin: 1.12.2023 -
AML Maintenance Part 2: a metaMORPHOsis?
Julkaistiin: 8.11.2023 -
AML Maintenance Part 1: Set Your QUAZARs to Stun
Julkaistiin: 25.10.2023 -
Episode 17: The Hemophilia Eras Tour
Julkaistiin: 23.8.2023 -
Common Sense Oncology: Outcomes That Matter
Julkaistiin: 1.8.2023 -
All too well: the reality of leukemia treatment
Julkaistiin: 8.6.2023
Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.
